JC Virus Infection
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT05305040) | AlloVir | 2022-03-24 |
| Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT04693637) | AlloVir | 2021-01-15 |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus (NCT02479698) | M.D. Anderson Cancer Center | 2015-07-23 |
| TETRAVI Expanded Access Program (NCT07104591) | Baylor College of Medicine |
Track JC Virus Infection automatically
Every clearance here is in the API, with alerts when new ones post.